News

British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
Section 2 – Product/Company Update Remote Pharmacy announces continued nationwide availability of its compounded GLP-1 formulations, including semaglutide and tirzepatide-based treatments, for ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as ...
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release ...